In a 64-year-old man with severe obstructive sleep apnea, BMI 42, Mallampati class IV, denture use, chronic osteomyelitis, and coronary artery disease treated with a left anterior descending artery stent, who has failed continuous positive airway pressure therapy despite multiple attempts and cannot afford a glucagon‑like peptide‑1 (GLP‑1) agonist, what is the next best step in management?

Hypoglossal Nerve Stimulation Therapy

For this 64-year-old man with severe OSA, BMI 42, CAD with LAD stent, and CPAP failure, hypoglossal nerve stimulation therapy (option d) is the next best step, though his BMI exceeds current guideline thresholds and requires careful evaluation.

Clinical Reasoning

This patient presents a challenging scenario where standard first-line therapy has failed despite appropriate troubleshooting. Let me walk through why each option does or doesn't fit:

Why Not Mandibular Advancement Device (MAD)?

The patient wears dentures, which is a critical contraindication. MADs require adequate dentition or implants for retention 1. The 2025 Portuguese consensus explicitly states that "lack of adequate retention (inadequate dentition or implants)" is a contraindication to MAD therapy 1. While MADs are recommended as an alternative to CPAP for patients who cannot tolerate PAP therapy 2, and the 2020 VA/DoD guidelines suggest them for mild-to-moderate OSA (AHI <30/h) 3, this patient's denture use makes this option non-viable.

Why Not Positional Therapy?

Positional therapy is not mentioned in any of the provided guidelines as appropriate management for severe OSA with BMI 42 and Mallampati class IV. This patient's anatomical severity (Mallampati IV, severe obesity) makes position-dependent OSA unlikely to be the primary mechanism.

Why Hypoglossal Nerve Stimulation?

The 2020 VA/DoD guidelines specifically recommend: "For patients with OSA with an AHI of 15–65/h and a body mass index <32 kg/m2 who cannot adhere to PAP, we suggest evaluation for surgical treatment with hypoglossal nerve stimulation therapy (weak for)" 3.

The critical issue: This patient's BMI is 42, exceeding the guideline threshold of <32 kg/m2. However, this remains the most appropriate option among those listed because:

1. CPAP failure is documented after extensive troubleshooting
2. MAD is contraindicated due to dentures
3. The patient has severe OSA with significant cardiovascular comorbidity (CAD with stent), making untreated OSA particularly dangerous for mortality and morbidity 4, 5
4. No other viable alternatives are presented in the question

Surgical Alternatives Not Listed

The 2011 European Respiratory Journal guidelines note that maxillomandibular advancement (MMA) "seems to be as efficient as CPAP in patients with OSA who refuse conservative treatment, particularly in a young OSA population without excessive BMI or other comorbidities" 6. However, at age 64 with BMI 42, this patient doesn't fit the ideal profile, and MMA is not among the answer choices.

Multilevel surgery (MLS) "cannot be recommended as a substitute for CPAP but as a salvage procedure for OSA patients in whom CPAP and other conservative therapies have failed" 6, but success is "often unpredictable and less effective than CPAP" (Grade C recommendation).

The BMI Barrier and Clinical Reality

This represents a genuine clinical dilemma. The patient's BMI of 42 technically excludes him from standard hypoglossal nerve stimulation criteria. However:

• Bariatric surgery should be discussed given BMI ≥35 with OSA and CPAP intolerance 7, 8, but this requires separate surgical evaluation and doesn't address immediate OSA management
• GLP-1 agonists are explicitly unavailable due to cost, eliminating pharmacologic weight loss 8, 9, 10, 11
• The patient has chronic osteomyelitis, which may complicate certain surgical approaches

Practical Next Steps

The answer is (d) hypoglossal nerve stimulation therapy, with the understanding that:

1. Refer for specialized surgical evaluation to determine if the patient could be considered despite BMI >32, as some centers may have expanded criteria or clinical trial protocols
2. Simultaneously pursue bariatric surgery consultation 7 given BMI 42 and CPAP failure—this addresses both OSA and cardiovascular risk
3. The chronic osteomyelitis requires coordination with infectious disease regarding surgical candidacy
4. Document the cardiovascular urgency: This patient with CAD and LAD stent has severe OSA, creating substantial risk for cardiovascular events, arrhythmias, and mortality if left untreated 4, 5

Common Pitfalls

• Don't assume MAD works with dentures—it requires adequate natural dentition or well-integrated implants
• Don't delay treatment in severe OSA with cardiovascular disease; untreated OSA significantly worsens CAD outcomes
• Don't forget weight management discussion even when GLP-1s are unaffordable—comprehensive lifestyle intervention and bariatric surgery referral remain options 7, 8
• BMI thresholds in guidelines are not absolute contraindications—they represent evidence-based recommendations, but individual patient evaluation by specialized centers may allow exceptions

The most honest answer is (d), recognizing this patient needs subspecialty surgical evaluation to determine actual candidacy, as he falls outside typical criteria but has no other viable options among those listed 3.